Endometriosis. Endometriosis
Conditions
Interventions
Intervention 1: Intervention Group: Lactobacilli tablets, once daily with the trade name "Lactofem" from Zist Takhmir Pharmaceutical Company which contains 10 to the power 9 colony count of the follow
daily 1 tablet of the placebo which is made by the pharmaceutical company Zist Takhmir with the exactly same packaging and appearance with "Lactofem". The tablet will be taken for 8 weeks and the pa
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 45 Years
Inclusion criteria
Inclusion criteria: Definitive diagnosis of endometriosis Menstrual cycle in the range of 21-35 days Aged 18-45 years Those who had VAS (Visual Analogue Scale) Score intensity of 5 or more for their pain intensity Passing at least 3 months and 1 year at the most since surgery
Exclusion criteria
Exclusion criteria: Patients who had received hormonal treatment during the past 3 months History of liver or renal disease history of carcinoma Patients with history of diarrhea after consuming dairy products Consumption of food or any type of probiotic product Those who had a pain intensity of less than 5 according to the VAS Score Patients who had received antibiotics during the past 3 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean VAS score. Timepoint: 8 and 12 weeks after starting of drug use. Method of measurement: VAS Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Drug Adverse Effects. Timepoint: 8 and 12 Weeks after starting drug use. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Sepideh Khodaverdi
Iran University of Medical Sciences
Outcome results
None listed